Delivery Order SPE2DR25D3301-SPE2DR26F18YB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pomalyst 4 mg capsules (21-count packages) on December 2, 2025, with a ceiling value of $43,792.86 and completion date of December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $14,597.62 to AmerisourceBergen Drug Corp for the supply of Pomalyst 4 mg capsules (21-count units) on November 13, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Pomalyst 1 mg capsules (100-count units) with a ceiling value of $292,457.73. This firm fixed price delivery order, with an ultimate completion date of May 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a $13,851.75 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Pomalyst 4 mg capsules (21-count units). This is a firm fixed-price, non-set-aside contract with performance scheduled for completion by August 29, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on December 15, 2025, with a ceiling value of $8,414.60 under firm fixed pricing. This non-set-aside delivery order is scheduled for ultimate completion on December 16, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is...
- The Defense Logistics Agency awarded a $14,592.57 delivery order (Contract No. 4570198891) to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies on December 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 8, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.46 to AmerisourceBergen Drug Corp on December 4, 2025, under the Pharmaceutical PV Division contract. This firm fixed price delivery order, which is not associated with a set-aside designation, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $3,582.06 to AmerisourceBergen Drug Corp on December 1, 2025, under a firm fixed-price contract. The order, which is part of the Pharmaceutical Prime Vendor Division, is scheduled for completion by December 2, 2025, and will be fulfilled at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued without set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $141,154.56 to AmerisourceBergen Drug Corp on December 15, 2025, for pharmaceutical and medical supply deliveries. This firm fixed-price delivery order, which is not set-aside and is competitively awarded, represents performance through December 16, 2025, and will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency issued a delivery order valued at $2,974.53 to AmerisourceBergen Drug Corp on December 10, 2025, under the Pharmaceutical PV (Prime Vendor) Division program. This firm fixed-price, competitively awarded delivery order is scheduled for completion by December 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18YBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Pomalyst 4 mg capsules (21-count units) with a ceiling value of $14,597.62. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle. The order is scheduled for ultimate completion by December 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medical commodities to support military and federal healthcare systems worldwide, including specialty medications, brand-name and generic drugs, and related medical supplies. The Pomalyst order represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare customers within the comprehensive global pharmaceutical support framework established under this prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 12/2/25 |